God is our Guide  Number 1 site for helping reverse diseases on Planet Earth
 

CidpUSA.org

 
Home
Diagnosis
Treatment
Pathology
Women Heart Risk
Women Killer Disease
Fibrmomyalgia
IVIG
Diet anti-inflammatory
Burning Feet Home
Services Page
Hepatitis
Autoimmune diseases
Prognosis
Bible healing
Pemphagoid

Statin Neuropathy

Statin kidney failure

Statin Visual loss

Statin and weakness

Statin polyneuropathy

Statins * Bleeding

Statin Memory loss

New cholesterol drug

Heart disease and Statin

Gluthione

Cancer

Circadian Rhythm

Sleep Benefits

Autoimmune self attack

Autoimmune anemia

Autoimmune Ear

 
Natural Makeup
Neck Pain
Ocular Female diseases
Chronic fatigue syndrome
Osteoporosis
Women Heart Attacks
Spices
RX all diseases
Vinegar
Memory problems
Breast Lymph Drainage
Kidney stone Buster
Bras cause breast cancer
Skin repair Clinic
Pandas
Hepatitis

 www.cidpusa.org/P/ivig.htm

 Information on Statin

    Guide to natural prevention/ treatment of autoimmune disease read our e-book
Statins May Spur Kidney Failure

Study: Statins Can Cause Kidney Failure

Friday, May 21, 2010 8:14 AM

Normal functioning kidney before a kidney transplant or kidney disease. Click image for larger view from www.medivisuals.com.

People using cholesterol-lowering statins have higher risks of liver dysfunction, kidney failure, muscle weakness, and cataracts, and such side effects of the drug should be closely tracked, doctors said on Friday.

In a study covering more than 2 million people in Britain, researchers from Nottingham University found that adverse side effects of statins, which are prescribed to people with high levels of cholesterol to cut the risk of heart disease, were generally worst in the first year of treatment. \

The findings, published in the British Medical Journal, are unlikely to affect the use of best-selling medicines like Pfizer's Lipitor and AstraZeneca's Crestor, but the study's authors said patients taking statins should be "proactively monitored" for side effects.

"Our study is likely to be useful for policy and planning purposes," said Julia Hippisley-Cox and Carol Coupland, the two professors who led the study. They said it may also be useful "for informing guidelines on the type and dose of statins."

Statins are among the most successful drugs of all time and have been credited with preventing millions of heart attacks and strokes. Heart disease is the biggest killer of men and women in the developed world and is also a growing health problem in developing nations.

In a commentary on the study, senior cardiologists Alawi Alsheikh-Al, of the Sheikh Khalifa Medical City in the United Arab Emirates, and Richard Karas of the Tufts University School of Medicine in the United States, said that, like any medical treatment, statins are not completely risk-free, but that when used properly, their benefits outweigh their dangers.

"It would be wise to interpret the present observations in the context of the confirmed cardioprotective effects of statins and remind ourselves and our patients that these drugs, although considered safe, are, like any intervention in medicine, not entirely free of adverse events," they wrote.

Coupland and Hippisley-Cox studied data from 368 general practices on 2,004,692 patients aged 30 to 84 years including 225,922 patients who were new statin users and had been prescribed a range of statins.

They found that for every 10,000 high-risk women treated with statins, the positive impact would be around 271 fewer cases of heart disease and eight fewer cases of esophageal cancer.

On the other side, there would also be 74 extra patients with liver dysfunction, 23 extra patients with acute renal failure, 307 with cataracts, and 39 with a muscle weakness condition called myopathy.

Similar figures were found for men except rates of myopathy were higher, they said. They noted that some of the effects might be due to better detection rates since patients taking statins are likely to consult their doctors more often.

The adverse effects were similar for all different types of statins, except for liver dysfunction, where the highest risks were found for fluvastatin, which is sold by Novartis under the brand names Lescol and Lochol.

"All of the increased risks persisted during the treatment, but were highest in the first year," they wrote.

Go to the nervous system

 
  •  myopathy, Lochol,statins,Crestor
  •  

     page